VivoSeq
Other

Vaccine Response

0

Pipeline Programs↗

4

Active Trials↗

1

Companies Involved↗

Vaccine Response is an early-stage landscape with 0 programs across 1 company. The most active players are Johnson & Johnson.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

91/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Johnson & Johnson logo

Johnson & Johnson

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

16

clinical trials

Completed10 · 63%
Recruiting2 · 13%
Withdrawn1 · 6%
Active, not recruiting1 · 6%
Unknown status1 · 6%
Not yet recruiting1 · 6%

Clinical Trials

Trial Activity

16 trials

Systems Investigation of Vaccine Responses in Aging and Frailty
Recruiting·YYale University·Phase 2·NCT05291676·96 enrolled
Durability of Vaccine Responses
Recruiting·EEmory University·Phase 4·NCT05801978·66 enrolled
Vaccine Responses in Cancer
Active, not recruiting·—·N/A·NCT06605625·250 enrolled
RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients
Not yet recruiting·TThe Cooper Health System·Phase 4·NCT07296120·30 enrolled
Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal Antibodies
Completed·CCentre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida·N/A·NCT04519710·60 enrolled
MTX Discontinuation and Vaccine Response
Completed·SSeoul National University Hospital·Phase 4·NCT02748785·277 enrolled
Systems Biological Assessment of Statin Effect on Vaccine Responses
Completed·EEmory University·Phase 4·NCT06024096·63 enrolled
Flu Vaccine Response in Patients on Biologic Therapies
Completed·SStony Brook University·Phase 2·NCT03277703·30 enrolled
Role of Interferon-λ and Vaccine Response
Completed·UUniversity Hospital, Basel, Switzerland·N/A·NCT03467074·200 enrolled
Zoster Vaccine Response in the Frail Elderly
Completed·MMcMaster University·N/A·NCT01328548·241 enrolled
Senescent Immunity in Elders and Vaccine Responses (SILVER)
Completed·VVanderbilt University Medical Center·Phase 4·NCT04077424·10 enrolled
A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 1·NCT05827874·32 enrolled
Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women
Completed·—·N/A·NCT05919472·180 enrolled
Effects of Aging on Primary and Secondary Vaccine Responses
Completed·SStanford University·Phase 1·NCT03312699·54 enrolled
Vaccine Response With NT-I7
Withdrawn·National Cancer Institute (NCI)·Phase 1·NCT04054752
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)